Target intelligence / Profile preview

X-ray attenuation by iodine

Molecular classification
Other (Physical property; not a molecule or receptor; sometimes related to "contrast agent" chemistry)
01

Overview

X-ray attenuation by iodine is a physical phenomenon central to radiological imaging diagnostics, based on iodine's high atomic number (Z=53) and specific K-edge (33.2 keV). When X-rays of appropriate energy interact with iodine, the probability of photoelectric absorption increases sharply, resulting in enhanced local absorption (attenuation) of X-ray photons. This property is harnessed in iodinated contrast media to improve tissue contrast in imaging modalities like CT. The process is not a drug or molecular target, but a physical principle underlying the use of iodine compounds in clinical imaging agents. Though not a biological target, the process carries important safety considerations—including increased DNA damage and radiation dose to tissues exposed to iodinated contrast agents, potentially raising cancer risks[2][3][7].

Other names
Iodine K-edge attenuationIodinated contrast mediaIodine-based CT contrast
02

Mechanism of action

Photoelectric effect (Iodine atoms absorb X-ray photons at energies near their K-shell binding energy, resulting in increased local attenuation and image contrast)[3][4][5][7]

03

Biological functions

Other (Facilitates radiological imaging by increasing contrast between tissues[3][4][7])
04

Disease associations

Other (Used across many imaging indications: tumors, cardiovascular disease, infection, organ imaging, etc.[3][7])
05

Safety considerations

Contrast-induced nephropathy (kidney injury)[3]Allergic or anaphylactoid reactions[3]Amplification of radiation dose and DNA damage, potentially increasing long-term cancer risk[2]Exacerbation of certain conditions (e.g., myasthenia gravis)[3]
06

Interacting drugs

Iohexol[7]

4 more in the full profile.

07

Biomarkers

Plasma/serum iodine concentration (to assess exposure)Circulating lymphocyte DNA double-strand breaks (as a biomarker for X-ray induced DNA damage in the presence of iodine contrast)[2]

Beyond the preview

Go deeper on X-ray attenuation by iodine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on X-ray attenuation by iodine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call